New Brunswick, NJ, United States of America

Jack A DeJovin

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Jack A DeJovin: Innovator in Dermatological Treatments

Introduction

Jack A DeJovin is a notable inventor based in New Brunswick, NJ (US), recognized for his contributions to dermatological treatments. With a total of 12 patents to his name, he has made significant advancements in methods for treating skin disorders, particularly psoriasis.

Latest Patents

Among his latest patents is a method for treating psoriasis, which describes methods and kits for treating or preventing psoriasis or symptoms associated with the condition. This innovative approach involves the topical application of a therapeutically effective amount of an α2 adrenergic receptor agonist. Additionally, he has developed compounds, formulations, and methods for treating or preventing inflammatory skin disorders, incorporating specific compounds in topical formulations.

Career Highlights

Throughout his career, Jack has worked with prominent companies in the pharmaceutical industry, including Galderma Laboratories Inc. and Galderma Pharma S.A. His work has focused on developing effective treatments for skin conditions, showcasing his commitment to improving patient care.

Collaborations

Jack has collaborated with several professionals in his field, including Isabelle Jean DeJovin and Michael Graeber. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Jack A DeJovin stands out as a significant figure in the field of dermatological innovation, with a strong portfolio of patents that reflect his dedication to advancing treatment options for skin disorders. His work continues to impact the lives of many individuals suffering from these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…